Kolexia
Frenzel Laurent
Rhumatologie
Hôpital Necker Enfants Malades
Paris, France
205 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Mastocytose Hémophilie A Tumeurs à plasmocytes Leucémies Mastocytose généralisée Hémorragie Lymphomes COVID-19

Industries

Janssen
34 collaboration(s)
Dernière en 2023
Sobi
29 collaboration(s)
Dernière en 2023
Amgen
25 collaboration(s)
Dernière en 2023
Sanofi
24 collaboration(s)
Dernière en 2023

Dernières activités

PRESent-2: A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
Essai Clinique (ApcinteX Ltd)   15 mars 2024
IsAMYP: A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus Pomalidomide and Dexamethasone (IPd), in Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
Essai Clinique (BMS)   05 mars 2024
PRESent-3: A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors
Essai Clinique (ApcinteX Ltd)   04 mars 2024
Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies
Research and practice in thrombosis and haemostasis   01 mars 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study on the behalf of G2I and IFM.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   01 mars 2024
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma: A Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy
Essai Clinique (Janssen)   27 février 2024
Emicizumab and asparaginase, A first experience to share.
Haemophilia : the official journal of the World Federation of Hemophilia   19 janvier 2024
PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.
Haemophilia : the official journal of the World Federation of Hemophilia   25 décembre 2023
Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review.
Haemophilia : the official journal of the World Federation of Hemophilia   18 décembre 2023